Findings may yield novel therapeutic strategies for late-stage breast cancer
 

Researchers from the Boston University School of Medicine (BUSM) have determined how the TGF?-Smad signaling pathway, which is over activated in late-stage cancers, is responsible for the "epigenetic memory" that maintains unique patterns of regulatory DNA hypermethylation causing silencing of critical genes that facilitate breast cancer progression.

More...